Why Axogen Stock Is Up Premarket

Axogen Inc. (NASDAQ: AXGN) is up 18% at $44.31 in premarket, versus $37.46 at the prior close. The company reported stronger quarterly results and raised its full-year revenue outlook, giving investors signs of faster sales growth and better earnings.

What Axogen Inc. Does

Axogen develops and sells surgical products to help repair peripheral nerves, the nerves outside the brain and spinal cord. More sales can mean more procedures using those products and a larger business.

Axogen Third Quarter Results

Revenue reached $75.8 million, up 26.2% from the same quarter a year earlier. Adjusted earnings were $0.21 per share; adjusted earnings leave out items the company does not count as part of its usual results. Those results show that sales growth came with stronger earnings.

Axogen Full-Year Revenue Outlook

Axogen raised its full-year revenue outlook to at least $290 million. It said that would mean growth of at least 29%. The higher target signals management expects growth to continue beyond the reported quarter.

Quick Financial Overview

Axogen is profitable, with a market value of $2.60B, the total value of its shares. It is a mid-cap, placing it in the market’s middle size range. It held $111.4M in cash, cash equivalents, and short-term investments as of June 30, 2026, including cash and investments readily turned into money.

Axogen Net Income and Gross Margin

Third-quarter net income was $2.3 million, while adjusted net income was $13.1 million after excluding items the company does not count as usual costs. Gross margin, the share of revenue left after direct product costs, was 74.8%.

Axogen Full-Year Margin and Cash Flow

Management also expects positive free cash flow for the full year. Free cash flow is the money left after operating costs and spending on long-term business assets. That goal tests whether sales growth also leaves money in the business.

Axogen Share Offering Risk

A September filing concerns a share offering, a sale of shares that can dilute current holders by reducing each holder’s ownership percentage. The filing’s terms are unavailable here, so the number of newly issued shares cannot be established.

Axogen Stock Is up 106% Over the Past Year

Before today’s premarket jump, AXGN had pulled back over the past month. The new move has carried the stock above its recorded high for that month. For Axogen, the last daily move this large was many sessions ago.

Conclusion

Axogen’s next quarterly earnings report will test whether sales growth and profit continue, but its date has not been announced here. Continued progress would support management’s goal, while weaker results would leave less room to meet it.